Neurological involvement is common in acquired immunodeficiency syndrome (AIDS). A subacute encephalitis now termed the """"""""AIDS dementia complex"""""""" (ADC) may afflict up to 80% of adult AIDS patients. ADC is characterized clinically by cognitive, motor and behavioral dysfunction. ADC occurs in the absence of recognized opportunistic pathogens, and there is strong indication that direct infection of the nervous system by human immunodeficiency virus type-1 (HIV-1) is responsible for the ADC. This application is based on the hypothesis that HIV-1 infection of astrocytes, the major glial cell of the central nervous system (CNS), contributes to the pathophysiology of ADC. There is both in vivo and in vitro evidence that astrocytes can be infected with HIV-1, and that astrocytes express the CD4 molecule, which is the receptor for HIV-1. Astrocytes perform a wide range of critical functions in the CNS, among them, maintaining a balanced microenvironment for neurons, responding to CNS infection/trauma, and functioning as an endogenous antigen- presenting cell in the CNS. Alterations in astrocyte function, either by direct infection with HIV-1 or by soluble factors from other HIV-1 infected cells direct will influence the overall functioning and integrity of the brain. We propose to investigate the effect of HIV-1 infection of human astrocytes with respect to 1) gene expression of astrocyte antigens, 2) cytokine production by HIV-1 infected astrocytes, 3) biological response of infected astrocytes to cytokines, 4) cytokine regulation of HIV-1 infection in astrocytes and 5) proteinase production/activity by infected astrocytes. These studies will provide functional information on how HIV-1 alters gene expression in astrocytes at both the transcriptional and translational level, how HIV-1 infected astrocytes respond to cytokines, and how cytokines that have biological effects on astrocytes may modulate HIV-1 activity in these cells. A consequence of HIV-1 of astrocytes may be an indirect effect on neuronal activity, thereby resulting in some of the neurological symptoms of ADC. Understanding how HIV-1 perturbs the biological activity of the astrocytes will provide insights into the pathogenesis of ADC.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Wilson, J E; Aulabaugh, A; Caligan, B et al. (1996) Human immunodeficiency virus type-1 reverse transcriptase. Contribution of Met-184 to binding of nucleoside 5'-triphosphate. J Biol Chem 271:13656-62
Dubay, J W; Dubay, S R; Shin, H J et al. (1995) Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J Virol 69:4675-82
Spies, C P; Ritter Jr, G D; Mulligan, M J et al. (1994) Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein alters the conformation of the external domain. J Virol 68:585-91
Norris, J G; Tang, L P; Sparacio, S M et al. (1994) Signal transduction pathways mediating astrocyte IL-6 induction by IL-1 beta and tumor necrosis factor-alpha. J Immunol 152:841-50
Clark, S J; Kelen, G D; Henrard, D R et al. (1994) Unsuspected primary human immunodeficiency virus type 1 infection in seronegative emergency department patients. J Infect Dis 170:194-7
Benveniste, E N (1994) Cytokine circuits in brain. Implications for AIDS dementia complex. Res Publ Assoc Res Nerv Ment Dis 72:71-88
Byrne, J A; Stankovic, A K; Cooper, M D (1994) A novel subpopulation of primed T cells in the human fetus. J Immunol 152:3098-106
Bray, M; Prasad, S; Dubay, J W et al. (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. Proc Natl Acad Sci U S A 91:1256-60
Borrow, P; Lewicki, H; Hahn, B H et al. (1994) Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 68:6103-10
Piatak Jr, M; Saag, M S; Yang, L C et al. (1993) High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-54

Showing the most recent 10 out of 58 publications